Organigram Global (OGI) Current Taxes (2022 - 2023)
Organigram Global (OGI) posted quarterly Current Taxes of $70117.5 for Q3 2023, down 93.65% on a QoQ basis from $1.1 million in Q3 2022.
Organigram Global (OGI) Current Taxes (2022 - 2023) Analysis & Trends
Organigram Global (OGI) has reported Current Taxes for 2 consecutive years, with $70117.5 the latest figure, recorded in Q3 2023.
- Quarterly Current Taxes changed N/A year-over-year to $70117.5 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $70117.5 (changed N/A YoY) and the FY2023 annual result came in at $69718.8, changed N/A from the prior year.
- Current Taxes declined to $70117.5 in Q3 2023 per OGI's latest filing, from $1.1 million in the prior quarter.
- Over the last five years, Current Taxes for OGI reached as high as $1.1 million in Q3 2022 and fell as low as $70117.5 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 70,117.46 |
| Aug 31, 2022 | 1.10 Mn |